Headlines Ingredients 
Quality Matters
AUGUST 22, 2023
Earlier this spring, the FDA requested further stakeholder input on approaches for identifying and testing novel nitrosamines identified in drug products and active pharmaceutical ingredients (APIs), and USP was one of numerous organizations that submitted comments to the agency.
pharmaphorum
JULY 28, 2022
Supply chain shortages have dominated headlines for several months, and the pharma industry has been no exception. Businesses are facing challenges in obtaining raw ingredients for medicines. With many ingredients shipped in from offshore, businesses need to consider logistics. The stakes are high. Logistical challenges.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Quality Matters
AUGUST 23, 2023
Earlier this spring, the FDA requested further stakeholder input on approaches for identifying and testing novel nitrosamines identified in drug products and active pharmaceutical ingredients (APIs), and USP was one of numerous organizations that submitted comments to the agency.
European Pharmaceutical Review
DECEMBER 13, 2022
In the absence of extensive available information on the toxicity of common formulation ingredients, ie, excipients, EG was used as a vehicle (72 percent w/v) in the formulation. DEG from impurities in ingredients like glycerine and polyethylene glycols in finished cosmetic products can be considered to be safe”.
Pharmaceutical Technology
JULY 14, 2022
Pharmaceutical companies regularly outsource different steps of drug manufacturing processes like parenteral manufacturing and packaging, solid dose, and small molecule or biologic active pharmaceutical ingredient (API) production, among others. Covid-19 vaccines stay in the spotlight.
Quality Matters
OCTOBER 10, 2023
Standards on the Frontlines: Responding to public health crises and strengthening supply chains Vulnerabilities or disruptions to the global medicine supply chain (including drug shortages) continue to make headlines. Ingredient testing by manufacturers can be used to successfully detect the presence of DEG, EG, and other poisons.
Quality Matters
APRIL 20, 2023
Examples include standards for both active and inactive pharmaceutical ingredients (excipients), distribution standards covering temperature excursions, and labeling standards that support health literacy. We also see complex generics that can have a complex active ingredient, formulation, route of delivery or device component.
Expert insights. Personalized for you.
98 
Let's personalize your content